Tema Oncology ETF (NASDAQ:CANC) Short Interest Update

Tema Oncology ETF (NASDAQ:CANC) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 7,400 shares, an increase of 13.8% from the December 15th total of 6,500 shares. Based on an average daily volume of 11,800 shares, the days-to-cover ratio is currently 0.6 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Tema Oncology ETF stock. Thrivent Financial for Lutherans purchased a new position in shares of Tema Oncology ETF (NASDAQ:CANC) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 319,376 shares of the company’s stock, valued at approximately $8,616,000. Thrivent Financial for Lutherans owned approximately 19.01% of Tema Oncology ETF at the end of the most recent reporting period.

Tema Oncology ETF Stock Down 0.1 %

Shares of CANC traded down $0.03 during trading hours on Friday, reaching $24.46. The stock had a trading volume of 27,892 shares, compared to its average volume of 50,936. The firm has a 50-day moving average of $25.87 and a 200 day moving average of $27.64. The company has a market cap of $57.48 million, a P/E ratio of 26.86 and a beta of 1.11. Tema Oncology ETF has a 52 week low of $23.97 and a 52 week high of $30.11.

Tema Oncology ETF Announces Dividend

The business also recently announced a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were issued a dividend of $0.7283 per share. The ex-dividend date was Wednesday, December 11th.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.